Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 3
2004 5
2005 14
2006 11
2007 4
2008 8
2009 4
2010 5
2011 9
2012 5
2013 8
2014 9
2015 7
2016 9
2017 2
2018 6
2019 9
2020 8
2021 14
2022 21
2023 19
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Results by year

Filters applied: . Clear all
Page 1
Effect of DMARDs on the immunogenicity of vaccines.
van Sleen Y, van der Geest KSM, Huckriede ALW, van Baarle D, Brouwer E. van Sleen Y, et al. Among authors: van baarle d. Nat Rev Rheumatol. 2023 Sep;19(9):560-575. doi: 10.1038/s41584-023-00992-8. Epub 2023 Jul 12. Nat Rev Rheumatol. 2023. PMID: 37438402 Review.
Profiling the SARS-CoV-2-specific T-cell response.
Geers D, Gommers L, Tan NH, Bogers S, van Baarle D, Grifoni A, Sette A, Boerma A, Visscher F, Richard M, Funk M, Zaeck LM, van der Kuy PHM, Haagmans BL, Koopmans MP, GeurtsvanKessel CH, de Vries RD. Geers D, et al. Among authors: van baarle d. Lancet Infect Dis. 2024 Aug;24(8):e477-e478. doi: 10.1016/S1473-3099(24)00377-3. Epub 2024 Jun 20. Lancet Infect Dis. 2024. PMID: 38909615 No abstract available.
Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.
Zaeck LM, Tan NH, Rietdijk WJR, Geers D, Sablerolles RSG, Bogers S, van Dijk LLA, Gommers L, van Leeuwen LPM, Rugebregt S, Goorhuis A, Postma DF, Visser LG, Dalm VASH, Lafeber M, Kootstra NA, Huckriede ALW, Haagmans BL, van Baarle D, Koopmans MPG; SWITCH-ON Research Group; van der Kuy PHM, GeurtsvanKessel CH, de Vries RD. Zaeck LM, et al. Among authors: van baarle d. Nat Commun. 2024 May 18;15(1):4224. doi: 10.1038/s41467-024-48414-x. Nat Commun. 2024. PMID: 38762522 Free PMC article. Clinical Trial.
The hallmarks of CMV-specific CD8 T-cell differentiation.
van den Berg SPH, Pardieck IN, Lanfermeijer J, Sauce D, Klenerman P, van Baarle D, Arens R. van den Berg SPH, et al. Among authors: van baarle d. Med Microbiol Immunol. 2019 Aug;208(3-4):365-373. doi: 10.1007/s00430-019-00608-7. Epub 2019 Apr 13. Med Microbiol Immunol. 2019. PMID: 30989333 Free PMC article. Review.
Vaccines to Protect Older Adults against Pneumococcal Disease.
van de Garde MDB, Knol MJ, Rots NY, van Baarle D, van Els CACM. van de Garde MDB, et al. Among authors: van baarle d. Interdiscip Top Gerontol Geriatr. 2020;43:113-130. doi: 10.1159/000504490. Epub 2020 Apr 9. Interdiscip Top Gerontol Geriatr. 2020. PMID: 32294656 Review.
Frailty is related to serum inflammageing markers: results from the VITAL study.
van Sleen Y, Shetty SA, van der Heiden M, Venema MCA, Gutiérrez-Melo N, Toonen EJM, van Beek J, Buisman AM, van Baarle D, Sauce D. van Sleen Y, et al. Among authors: van baarle d. Immun Ageing. 2023 Nov 27;20(1):68. doi: 10.1186/s12979-023-00391-3. Immun Ageing. 2023. PMID: 38012652 Free PMC article.
Antibody signatures against viruses and microbiome reflect past and chronic exposures and associate with aging and inflammation.
Andreu-Sánchez S, Ripoll-Cladellas A, Culinscaia A, Bulut O, Bourgonje AR, Netea MG, Lansdorp P, Aubert G, Bonder MJ, Franke L, Vogl T, van der Wijst MGP, Melé M, Van Baarle D, Fu J, Zhernakova A. Andreu-Sánchez S, et al. Among authors: van baarle d. iScience. 2024 May 16;27(6):109981. doi: 10.1016/j.isci.2024.109981. eCollection 2024 Jun 21. iScience. 2024. PMID: 38868191 Free PMC article.
184 results